Swallowing therapy showed no clear difference in death or dependency at end of trial compared with placebo (moderate certainty).
Swallowing therapy showed no clear difference in case fatality at end of trial compared with placebo (moderate certainty).
Swallowing therapy may leads to lower proportion of participants with dysphagia at end of trial compared with placebo (low certainty).
It is very uncertain whether swallowing therapy changes adverse event: chest infection or pneumonia compared with placebo (very low certainty).
Endovascular coiling probably leads to lower poor outcome: death or dependence in daily activities (12 months) compared with neurosurgical clipping (moderate certainty).
Endovascular coiling showed no clear difference in death from any cause (12 months) compared with neurosurgical clipping (moderate certainty).
Endovascular coiling probably leads to lower delayed cerebral ischaemia (2–3 months) compared with neurosurgical clipping (moderate certainty).
Endovascular coiling leads to higher rebleeding postprocedure up to 1 year compared with neurosurgical clipping (high certainty).
Endovascular coiling showed no clear difference in complications from the intervention compared with neurosurgical clipping (low certainty).
It is very uncertain whether acupuncture changes death or dependency at end of compared with all control (sham and open) (very low certainty).
Acupuncture showed no clear difference in death or dependency at end of compared with sham control (low certainty).
Acupuncture may leads to lower death or institutional care at end of compared with sham control (low certainty).
Acupuncture showed no clear difference in death within first 2 weeks compared with sham control (low certainty).
Acupuncture showed no clear difference in death during whole compared with sham control (low certainty).
Acupuncture showed no clear difference in adverse events related to acupuncture compared with sham control (low certainty).